333 related articles for article (PubMed ID: 33350506)
1. Vitiligo: an update on systemic treatments.
Searle T; Al-Niaimi F; Ali FR
Clin Exp Dermatol; 2021 Mar; 46(2):248-258. PubMed ID: 33350506
[TBL] [Abstract][Full Text] [Related]
2. Medical and Maintenance Treatments for Vitiligo.
Passeron T
Dermatol Clin; 2017 Apr; 35(2):163-170. PubMed ID: 28317526
[TBL] [Abstract][Full Text] [Related]
3. Different Advanced Therapeutic Approaches to Treat Vitiligo.
Sharma CK; Sharma M; Aggarwal B; Sharma V
J Environ Pathol Toxicol Oncol; 2015; 34(4):321-34. PubMed ID: 26756425
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of 308-nm excimer laser/light (EL) and topical agent combination therapy versus EL monotherapy for vitiligo: A systematic review and meta-analysis of randomized controlled trials (RCTs).
Bae JM; Hong BY; Lee JH; Lee JH; Kim GM
J Am Acad Dermatol; 2016 May; 74(5):907-15. PubMed ID: 26785803
[TBL] [Abstract][Full Text] [Related]
5. Phototherapy for vitiligo, what's new?
Paro Vidolin A; Aurizi C; Leone G
G Ital Dermatol Venereol; 2017 Oct; 152(5):474-488. PubMed ID: 28906087
[TBL] [Abstract][Full Text] [Related]
6. Effect of topical calcineurin inhibitors as monotherapy or combined with phototherapy for vitiligo treatment: a meta-analysis.
Dang YP; Li Q; Shi F; Yuan XY; Liu W
Dermatol Ther; 2016; 29(2):126-33. PubMed ID: 26460804
[TBL] [Abstract][Full Text] [Related]
7. Vitiligo treatment update.
Daniel BS; Wittal R
Australas J Dermatol; 2015 May; 56(2):85-92. PubMed ID: 25495880
[TBL] [Abstract][Full Text] [Related]
8. Vitiligo: an update on current pharmacotherapy and future directions.
Colucci R; Lotti T; Moretti S
Expert Opin Pharmacother; 2012 Sep; 13(13):1885-99. PubMed ID: 22835073
[TBL] [Abstract][Full Text] [Related]
9. Vitiligo--Part 2--classification, histopathology and treatment.
Faria AR; Tarlé RG; Dellatorre G; Mira MT; Castro CC
An Bras Dermatol; 2014; 89(5):784-90. PubMed ID: 25184918
[TBL] [Abstract][Full Text] [Related]
10. The long-term risk of lymphoma and skin cancer did not increase after topical calcineurin inhibitor use and phototherapy in a cohort of 25,694 patients with vitiligo.
Ju HJ; Han JH; Kim MS; Lee SH; Shin JW; Choi M; Jeong KH; Han TY; Choi CW; Lee HJ; Oh SH; Lee SH; Kim DH; Shin J; Lee JH; Kim SS; Kang HY; Chang SE; Kim JS; Lee DY; Choi GS; Suh DH; Chan Kim Y; Park CJ; Kim KH; Lee AY; Chan Park K; Lee MH; Bae JM;
J Am Acad Dermatol; 2021 Jun; 84(6):1619-1627. PubMed ID: 33508387
[TBL] [Abstract][Full Text] [Related]
11. Vitiligo Treatments: Review of Current Therapeutic Modalities and JAK Inhibitors.
Cunningham KN; Rosmarin D
Am J Clin Dermatol; 2023 Mar; 24(2):165-186. PubMed ID: 36715849
[TBL] [Abstract][Full Text] [Related]
12. Guidelines for the management of vitiligo: the European Dermatology Forum consensus.
Taieb A; Alomar A; Böhm M; Dell'anna ML; De Pase A; Eleftheriadou V; Ezzedine K; Gauthier Y; Gawkrodger DJ; Jouary T; Leone G; Moretti S; Nieuweboer-Krobotova L; Olsson MJ; Parsad D; Passeron T; Tanew A; van der Veen W; van Geel N; Whitton M; Wolkerstorfer A; Picardo M; ; ;
Br J Dermatol; 2013 Jan; 168(1):5-19. PubMed ID: 22860621
[TBL] [Abstract][Full Text] [Related]
13. Treatment outcomes of vitiligo in Asian children.
Tay EY; Chong CLV; Chong WJJP; Gan YE; Chuah SY; Tan WDV; Thng TGS
Pediatr Dermatol; 2018 Mar; 35(2):265-267. PubMed ID: 29436008
[TBL] [Abstract][Full Text] [Related]
14. A systematic review of case series and clinical trials investigating systemic oral or injectable therapies for the treatment of vitiligo.
Jafarzadeh A; Pour Mohammad A; Khosravi M; Amiri S; Rasouli A; Keramati H; Goodarzi A
Skin Res Technol; 2024 Mar; 30(3):e13642. PubMed ID: 38454597
[TBL] [Abstract][Full Text] [Related]
15. [Not Available].
Darrigade AS
Ann Dermatol Venereol; 2019 Dec; 146(12S3):12S85-12S95. PubMed ID: 31997737
[TBL] [Abstract][Full Text] [Related]
16. Home phototherapy in vitiligo.
Mohammad TF; Silpa-Archa N; Griffith JL; Lim HW; Hamzavi IH
Photodermatol Photoimmunol Photomed; 2017 Sep; 33(5):241-252. PubMed ID: 28620923
[TBL] [Abstract][Full Text] [Related]
17. Controversial issues in vitiligo patients: a review of old and recent treatments.
Lotti T; Gianfaldoni S; Valle Y; Rovesti M; Feliciano C; Satolli F
Dermatol Ther; 2019 Jan; 32(1):e12745. PubMed ID: 30221810
[TBL] [Abstract][Full Text] [Related]
18. A review of JAK and IL-23 inhibitors to treat vitiligo.
Lee H; Cowan TL; Daniel BS; Murrell DF
Australas J Dermatol; 2023 May; 64(2):204-212. PubMed ID: 36810815
[TBL] [Abstract][Full Text] [Related]
19. Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo: a randomized multicenter trial.
Lim HW; Grimes PE; Agbai O; Hamzavi I; Henderson M; Haddican M; Linkner RV; Lebwohl M
JAMA Dermatol; 2015 Jan; 151(1):42-50. PubMed ID: 25230094
[TBL] [Abstract][Full Text] [Related]
20. Childhood Vitiligo.
Nicolaidou E; Mastraftsi S; Tzanetakou V; Rigopoulos D
Am J Clin Dermatol; 2019 Aug; 20(4):515-526. PubMed ID: 30911977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
